Position in AZN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$422,094
-$18,298 QoQ
Shares Held
2,226
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#909
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DeDora Capital, Inc. holds $14,607,227 across 7 Drug Manufacturers - General names. AZN ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,644 | $4,370,723 | |
| 2 | ABBV |
AbbVie Inc.
|
15,149 | $3,812,094 | |
| 3 | AMGN |
Amgen Inc
|
7,475 | $2,706,847 | |
| 4 | JNJ |
Johnson & Johnson
|
6,554 | $1,664,519 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,956 | $1,279,346 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,226 | $422,094 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,783 | $351,604 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $422,094 | 2,226 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $440,392 | 2,233 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||